Skip to main content
RYTM
NASDAQ Life Sciences

Second Bidder Emerges for Rhythm, Lifting Shares 4.2%

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$109.39
Mkt Cap
$7.584B
52W Low
$74.5
52W High
$122.2
52W Position info
47% above low
Off High info
10% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

RYTM sits 47% above its 52-week low of $74.5.

Summary

A second, unnamed bidder — speculated to be one of the world's largest pharma companies — has reportedly made a counteroffer for Rhythm, per a Betaville 'uncooked' alert cited by traders. Shares rose 4.2% on the report. This follows the WSJ report Wednesday that AstraZeneca offered about $124 per share, roughly $10 billion, for the biotech. A competing bid would put Rhythm in play at a higher price and raises the odds of an auction rather than a single-buyer negotiation. The source is an unconfirmed market rumor, so treat the identity and terms as unverified until a filing or confirmed report lands. AstraZeneca is the previously reported suitor; Rhythm is the primary affected company.

At the time of this announcement, RYTM was trading at $109.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.6B. The 52-week trading range was $74.50 to $122.20. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

RYTM - Latest Insights

RYTM
Nov 16, 2026, 4:00 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $107.31
Real-time Price: $113.50 info
Change: +$6.19 (+6%) info
Market Cap: $7.79B info
RYTM
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $109.75
Real-time Price: $113.50 info
Change: +$3.75 (+3%) info
Market Cap: $7.79B info
RYTM
Nov 04, 2026, 3:57 PM EST
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $95.21
Real-time Price: $113.50 info
Change: +$18.29 (+19%) info
Market Cap: $7.79B info
RYTM
Nov 04, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $85.70
Real-time Price: $113.50 info
Change: +$27.80 (+32%) info
Market Cap: $7.79B info
RYTM
Nov 04, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $88.42
Real-time Price: $113.50 info
Change: +$25.08 (+28%) info
Market Cap: $7.79B info